...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

I hope folks who push for DM to leave have your post bookmarked.  Dreams of a new CEO to turn your shares into vast riches can easily turn into a nightmare.

Share
New Message
Please login to post a reply